Erratum to: Sequential (hFSH + recFSH) vs homogenous (hFSH or recFSH alone) stimulation: Clinical and biochemical (cumulus cell gene expression) aspects (Journal of Assisted Reproduction and Genetics (2014) 31, (657-665) DOI: 10.1007/s10815-014-0208-1);Sequential (hFSH + recFSH) vs homogenous (hFSH or recFSH alone) stimulation: Clinical and biochemical (cumulus cell gene expression) aspects

Journal of Assisted Reproduction and Genetics

Volumn 31, Issue 6, 2014, Pages 657-665

  Gurgan, Timur ^a,b   Montjean, Debbie ^c   Demirol, Aygul ^b   Menezo, Yves J R ^d  

^a HACETTEPE UNIVERSITY   (Turkey)

^b The Gurgan clinic   (Turkey)

^c Service de Médecine et Biologie de la Reproduction   (France)

^d Laboratoire Clément   (France)

Author keywords

Cumulus cells; hFSH; recFSH; Sequential stimulation; Transcriptome

Indexed keywords

FOLATE RECEPTOR 1; FOLLITROPIN; HUMAN DERIVED FOLLITROPIN; OVOSTATIN 2; PROTEIN; RECOMBINANT FOLLITROPIN; TRANSCRIPTOME; UNCLASSIFIED DRUG; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CELL ADHESION; CELL CYCLE PROGRESSION; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CHOLESTEROL METABOLISM; CLINICAL FEATURE; CONTROLLED STUDY; CUMULUS CELL; EMBRYO DEVELOPMENT; ENDOMETRIAL THICKNESS; FEMALE; FERTILIZATION; GENE EXPRESSION; GENOTYPE; HOMOGENOUS STIMULATION; HORMONAL REGULATION; HUMAN; IMPLANTATION; IN VITRO STUDY; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; NUCLEIC ACID METABOLISM; OOCYTE; OOCYTE MATURATION; OVULATION; PREGNANCY RATE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SEQUENTIAL STIMULATION; DRUG EFFECTS; FERTILIZATION IN VITRO; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IN VITRO OOCYTE MATURATION; METABOLISM; OVARY FOLLICLE; OVULATION INDUCTION; PREGNANCY; PROCEDURES;

CUMULUS CELLS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE, HUMAN; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IN VITRO OOCYTE MATURATION TECHNIQUES; OOCYTES; OVARIAN FOLLICLE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; RECOMBINANT PROTEINS;

EID: 84904124228     PISSN: 10580468     EISSN: 15737330     Source Type: Journal    
DOI: 10.1007/s10815-014-0313-1     Document Type: Erratum

References (42)

1. Hussein TS, Thompson JG, Gilchrist RB. Oocyte-secreted factors enhance oocyte developmental competence. Dev Biol. 2006;296:514-21. (Pubitemid 44189356)
2. Foote WD, Thibault C. Recherches experimentales sur la maturation in vitro des ovocytes de truie et de de veau. Ann Biol Anim Biochim Biophys. 1969;9:329-49.
3. Wide L, Eriksson K, Sluss PM, Hall JE. Serum half-life of pituitary gonadotropins is decreased by sulfonation and increased by sialylation in women. J Clin Endocrinol Metab. 2009;94:958-64.
4. Wide L, Eriksson K. Dynamic changes in glycosylation and glycan composition of serum FSH and LH during natural ovarian stimulation. Ups J Med Sci. 2013;118:153-64.
5. Lombardi A, Andreozzi C, Pavone V, Triglione V, Angiolini L, Caccia P. Evaluation of the oligosaccharide composition of commercial follicle stimulating hormone preparations. Electrophoresis. 2013;34:2394-406.
6. Ulloa-Aguirre A, Timossi C, Barrios-de-Tomasi J, Maldonado A, Nayudu P. Impact of carbohydrate heterogeneity in function of follicle-stimulating hormone: studies derived from in vitro and in vivo models. Biol Reprod. 2003;69:379-89. (Pubitemid 36885939)
7. Yding AC. Effect of FSH and its different isoforms on maturation of oocytes from pre-ovulatory follicles. Reprod BioMed Online. 2002;5:232-9.
8. Nayudu PL, Vitt UA, Barrios De Tomasi J, Pancharatna K, Ulloa-Aguirre A. Intact follicle culture: what it can tell us about the roles of FSH glycoforms during follicle development. Reprod BioMed Online. 2002;5:240-53.
9. de Vitt UA, Kloosterboer HJ, Rose UM, Mulders JW, Kiesel PS, Bete S, et al. Isoforms of human recombinant follicle-stimulating hormone: comparison of effects on murine follicle development in vitro. Biol Reprod. 1998;59:854-61. (Pubitemid 28463337)
10. Wide L, Naessén T, Sundström-Poromaa I, Eriksson K. Sulfonation and sialylation of gonadotropins in women during the menstrual cycle, after menopause, and with polycystic ovarian syndrome and in men. J Clin Endocrinol Metab. 2007;92:4410-7. (Pubitemid 350074764)
11. Zambrano E, Olivares A, Mendez JP, Guerrero L, Díaz-Cueto L, Veldhuis JD, et al. Dynamics of basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle. J Clin Endocrinol Metab. 1995;80:1647-56.
12. Anserini P, Costa M, Remorgida V, Venturini PL. A prospective, randomized, controlled clinical study of a new subcutaneous, purified, urinary FSH preparation for controlled ovarian hyperstimulation in in vitro fertilization. Gynecol Endocrinol. 2000;14:75-80. (Pubitemid 30307214)
13. Gerli S, Perino M, Abate A, Costabile L, Gholami H, Vitiello L. Ovarian stimulation using a new highly purified urinary FSH: a prospective randomized clinical study. Clin Exp Obstet Gynecol. 1999;26:93-4. (Pubitemid 29322121)
14. Pang SC. A pen injection device for self-administration of recombinant follicle-stimulating hormone for fertility treatments. Expert Rev Med Devices. 2005;2:27-32. (Pubitemid 40124897)
15. Lispi M, Bassett R, Crisci C, Mancinelli M, Martelli F, Ceccarelli D, et al. Comparative assessment of the consistency and quality of a highly purified FSHextracted fromhuman urine (urofollitropin) and a recombinant human FSH(follitropin alpha). Reprod BioMed Online. 2006;13:179-93. (Pubitemid 44207764)
16. Check JH, Liss JR, Shucoski K, Check ML. Effect of short follicular phase with follicular maturity on conception outcome. Clin Exp Obstet Gynecol. 2003;30:195-6. (Pubitemid 37456313)
17. Cerpa-Poljak A, Bishop LA, Hort YJ, Chin CK, DeKroon R, Mahler SM, et al. Isoelectric charge of recombinant human folliclestimulating hormone isoforms determines receptor affinity and in vitro bioactivity. Endocrinology. 1993;132:351-6. (Pubitemid 23019523)
18. Assou S, Haouzi D, Mahmoud K, Aouacheria A, Guillemin Y, Pantesco V, et al. A non-invasive test for assessing embryo potential by gene expression profiles of human cumulus cells: a proof of concept study. Mol Hum Reprod. 2008;14:711-9.
19. Assou S, Haouzi D, De Vos J, Hamamah S. Human cumulus cells as biomarkers for embryo and pregnancy outcomes. Mol Hum Reprod. 2010;16:531-8.
20. Huang Z, Wells D. The human oocyte and cumulus cells relationship: new insights from the cumulus cell transcriptome. Mol Hum Reprod. 2010;16:715-25.
21. Hamel M, Dufort I, Robert C, Gravel C, Leveille MC, Leader A, et al. Identification of differentially expressed markers in human follicular cells associated with competent oocytes. Hum Reprod. 2008;23:1118-27. (Pubitemid 351757316)
22. Tosti E, Menezo Y. Sperm induced oocyte activation in Human Spermatozoa: Maturation, Capacitation and abnormalities. In: Lejeune T, Delvaux P, editors. Nova Science Publishers; 2010. pp. 379-397.
23. Eid LN, Lorton SP, Parrish JJ. Paternal influence on S-phase in the first cell cycle of the bovine embryo. Biol Reprod. 1994;51:1232-7. (Pubitemid 24354283)
24. Ward F, Rizos D, Corridan D, Quinn K, Boland M, Lonergan P. Paternal influence on the time of first embryonic cleavage post insemination and the implications for subsequent bovine embryo development in vitro and fertility in vivo. Mol Reprod Dev. 2001;60:47-55. (Pubitemid 32730311)
25. Menezo Jr Y, Russo G, Tosti E, El Mouatassim S, Benkhalifa M. Expression profile of genes coding for DNA repair in human oocytes using pangenomic microarrays, with a special focus on ROS linked decays. J Assist Reprod Genet. 2007;24:513-20. (Pubitemid 350231557)
26. Selman H, Pacchiarotti A, El-Danasouri I. Ovarian stimulation protocols based on follicle-stimulating hormone glycosylation pattern: impact on oocyte quality and clinical outcome. Fertil Steril. 2010;94:1782-6.
27. Selman H, Pacchiarotti A, Rinaldi L, Crescenzi F, Lanzilotti G, Lofino S, et al. Simultaneous administration of human acidic and recombinant less acidic follicle-stimulating hormone for ovarian stimulation improves oocyte and embryo quality, and clinical outcome in patients with repeated IVF failures. Eur Rev Med Pharmacol Sci. 2013;17:1814-9.
28. Pacchiarotti A, Aragona C, Gaglione R, Selman H. Efficacy of a combined protocol of urinary and recombinant follicle-stimulating hormone used for ovarian stimulation of patients undergoing ICSI cycle. J Assist Reprod Genet. 2007;24:400-5. (Pubitemid 47497959)
29. Pellicer A, Valbuena D, Cano F, Remohí J, Simón C. Lower implantation rates in high responders: evidence for an altered endocrine milieu during the preimplantation period. Fertil Steril. 1996;65:1190-5. (Pubitemid 26158638)
30. Seli E, Robert C, Sirard MA. OMICS in assisted reproduction: possibilities and pitfalls. Mol Hum Reprod. 2010;16:513-30.
31. Patrizio P, Sakkas D. Fromoocyte to baby: a clinical evaluation of the biological efficiency of in vitro fertilization. Fertil Steril. 2009;91:1061-6.
32. Wathlet S, Adriaenssens T, Segers I, Verheyen G, Janssens R, Coucke W, et al. New candidate genes to predict pregnancy outcome in single embryo transfer cycles when using cumulus cell gene expression. Fertil Steril. 2012;98:432-9.
33. van Montfoort AP, Geraedts JP, Dumoulin JC, Stassen AP, Evers JL, Ayoubi TA. Differential gene expression in cumulus cells as a prognostic indicator of embryo viability: a microarray analysis. Hum Reprod. 2007;22:3069-77.
34. Market Velker BA, Denomme MM, Mann MR. Loss of genomic imprinting in mouse embryos with fast rates of preimplantation development in culture. Biol Reprod. 2012;86(143):1-16.
35. El Mouatassim S, Bilotto S, Russo GL, Tosti E, Menezo Y. APEX/Ref-1 (apurinic/apyrimidic endonuclease DNA-repair gene) expression in human and ascidian (Ciona intestinalis) gametes and embryos. Mol Hum Reprod. 2007;13(8):549-56. (Pubitemid 47241909)
36. Sendler E, Johnson GD, Mao S, Goodrich RJ, Diamond MP, Hauser R, et al. Stability, delivery and functions of human sperm RNAs at fertilization. Nucleic Acids Res. 2013;41:4104-17.
37. Feuerstein P, Cadoret V, Dalbies-Tran R, Guerif F, Bidault R, Royere D. Gene expression in human cumulus cells: one approach to oocyte competence. Mol Hum Reprod. 2008;14:157-68.
38. Ménézo Y, Pluntz L, Chouteau J, Gurgan T, Demirol A, Dalleac A, et al. Zinc concentrations in serum and follicular fluid during ovarian stimulation and expression of Zn2+ transporters in human oocytes and cumulus cells. Reprod BioMed Online. 2011;22:647-52.
39. García-Herrero S, Garrido N, Martínez-Conejero JA, Remohí J, Pellicer A, Meseguer M. Differential transcriptomic profile in spermatozoa achieving pregnancy or not via ICSI. Reprod BioMed Online. 2011;22:25-36.
40. Ménézo Y, Lichtblau I, Elder K. New insights into human preimplantation metabolism in vivo and in vitro. J Assist Reprod Genet. 2013;30:293-303.
41. Ménézo Y, Mares P, Cohen M, Brack M, Viville S, Elder K. Autism, imprinting and epigenetic disorders: a metabolic syndrome linked to anomalies in homocysteine recycling starting in early life? J Assist Reprod Genet. 2011;28:1143-5.
42. Surén P, Roth C, Bresnahan M, Haugen M, Hornig M, Hirtz D, et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children. JAMA. 2013;309:570-7.